Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$176.32 - $240.22 $2.64 Million - $3.6 Million
15,000 Added 75.0%
35,000 $7.59 Million
Q1 2023

May 15, 2023

BUY
$161.33 - $204.36 $806,650 - $1.02 Million
5,000 Added 33.33%
20,000 $3.63 Million
Q2 2022

Aug 15, 2022

BUY
$93.97 - $143.33 $1.41 Million - $2.15 Million
15,000 New
15,000 $1.9 Million
Q4 2021

Feb 11, 2022

SELL
$110.64 - $159.4 $708,096 - $1.02 Million
-6,400 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$101.2 - $125.87 $647,680 - $805,568
6,400 New
6,400 $783,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.